Craft

Sangui Biotech International

Stock Price

$0

2024-10-29

Market Capitalization

$314.9 K

2024-10-29

Revenue

$69.2 K

FY, 2022

Sangui Biotech International Summary

Company Summary

Overview
Sangui BioTech International is a company that develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. Its artificial oxygen carriers provide oxygen transport in humans in the event of acute or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds.
Type
Public
Status
Active
Founded
1995
HQ
Farmington, UT, US | view all locations
Website
http://sanguibiotech.com
Cybersecurity rating
Sectors

LocationsView all

2 locations detected

  • Farmington, UT HQ

    United States

    291 S 200 W

  • Hamburg, HH

    Germany

    Bleichenbrücke 9

Sangui Biotech International Financials

Summary Financials

Revenue (Q3, 2023)
$18.7K
Gross profit (Q3, 2023)
$18.7K
Net income (Q3, 2023)
($38.5K)
Cash (Q3, 2023)
$7.0K
EBIT (Q3, 2023)
($22.9K)
Enterprise value
$1.1M

Footer menu